Coeptis Therapeutics Holdings Inc. Common Stock (COEP) Revenue (2019 - 2026)
Coeptis Therapeutics Holdings Inc. Common Stock (COEP) revenue from Mar 31, 2019 to Mar 31, 2026. The TTM Coeptis Therapeutics Holdings Inc. Common Stock (COEP) revenue is $1.41M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Coeptis Therapeutics Holdings Inc. Common Stock (COEP) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2250.00% |
Annual Revenue change of Coeptis Therapeutics Holdings Inc. Common Stock (COEP)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $110K | -91.91% |
| 2025 | $1.36M | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | -100.00% |
| 2021 | $80K | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |